Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.36
-0.03 (-2.16%)
At close: Aug 15, 2025, 3:59 PM
1.38
1.10%
After-hours: Aug 15, 2025, 05:51 PM EDT
Acrivon Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Dec 31, 2021 |
Cash & Equivalents | 41.9M | 39.15M | 39.82M | 43.41M | 46.01M | 24.61M | 36.02M | 29.86M | 38.07M | 27.49M | 29.52M | 32.08M | 83.86M | 99.6M |
Short-Term Investments | 95.53M | 110.48M | 139.66M | 144.04M | 134.53M | 85.37M | 91.44M | 112.23M | 112.88M | 92.72M | 98.23M | 44.74M | n/a | n/a |
Long-Term Investments | 10.2M | 15.2M | 5.09M | 15.39M | 40.32M | 417K | 414K | 411K | 408K | 39.27M | 41.88M | 388K | n/a | n/a |
Other Long-Term Assets | 1.85M | 1.84M | 1.84M | 1.84M | 468K | 348K | 251K | n/a | n/a | 388K | 4.73M | 1.54M | 612K | 388K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 989K | 1.69M | 2.15M | 1.53M | 1.82M | 2.17M | 2.23M | 2.4M | 2.33M | 3.75M | 4.34M | n/a | n/a | n/a |
Total Current Assets | 138.41M | 151.33M | 181.63M | 188.98M | 182.36M | 112.14M | 129.69M | 144.49M | 153.28M | 123.96M | 127.75M | 78.67M | 87.16M | 100.41M |
Property-Plant & Equipment | 8.12M | 7.98M | 8.03M | 8.47M | 7.44M | 7.61M | 7.91M | 6.19M | 6.36M | 6.57M | 6.86M | 7.11M | 7.22M | 5.79M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.17M | 25.02M | 14.96M | 25.7M | 48.23M | 8.38M | 8.57M | 6.6M | 6.77M | 46.23M | 53.48M | 9.04M | 7.83M | 6.18M |
Total Assets | 158.58M | 176.35M | 196.59M | 214.68M | 230.59M | 120.52M | 138.26M | 151.09M | 160.05M | 170.2M | 181.23M | 87.71M | 95M | 106.59M |
Account Payables | 1.16M | 3.69M | 758K | 1.51M | 1.26M | 2.06M | 5.05M | 1.5M | 1.27M | 1.37M | 904K | 1.98M | 1.9M | 964K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 69K | n/a | n/a | 66K |
Short-Term Debt | 1.15M | 1.1M | 1.06M | 1.04M | 978K | 944K | 877K | 776K | 753K | 740K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 12.28M | 1.03M | 4.4M | 2.99M | 5.12M | 965K | 2.98M | 3.24M | 2.18M | 1.42M | 2.15M | 2.4M | 881K | 667K |
Total Current Liabilities | 13.43M | 13.55M | 17.21M | 14.82M | 11.28M | 9.04M | 13.3M | 9.3M | 7.02M | 5.68M | 6.52M | 6.39M | 4.45M | 2.91M |
Long-Term Debt | 2.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 122.52M | 122.52M | 122.52M |
Total Long-Term Liabilities | 2.12M | 2.41M | 2.59M | 2.97M | 3.24M | 3.5M | 3.77M | 3.64M | 3.85M | 4.05M | 4.24M | 126.94M | 127.12M | 127.48M |
Total Liabilities | 15.55M | 15.96M | 19.8M | 17.79M | 14.53M | 12.54M | 17.07M | 12.94M | 10.87M | 9.73M | 10.75M | 133.33M | 131.57M | 130.4M |
Total Debt | 3.26M | 3.51M | 3.65M | 4.01M | 4.22M | 4.45M | 4.64M | 4.42M | 4.6M | 4.79M | 4.96M | 5.14M | 5.31M | 5.63M |
Common Stock | 31K | 31K | 31K | 31K | 31K | 23K | 23K | 22K | 22K | 22K | 22K | 2K | 2K | 2K |
Retained Earnings | -237.66M | -216.66M | -196.98M | -174.15M | -151.7M | -132.91M | -116.42M | -97.17M | -82.7M | -68.79M | -56.03M | -47.1M | -37.91M | -24.86M |
Comprehensive Income | 106K | 283K | 447K | 782K | -19K | -70K | -83K | -302K | -427K | 9K | -95K | -133K | n/a | n/a |
Shareholders Equity | 143.04M | 160.39M | 176.79M | 196.89M | 216.06M | 107.98M | 121.19M | 138.15M | 149.18M | 160.47M | 170.47M | -45.62M | -36.58M | -23.81M |
Total Investments | 105.73M | 125.68M | 144.75M | 159.43M | 174.85M | 85.78M | 91.86M | 112.23M | 112.88M | 132M | 140.11M | 44.74M | n/a | n/a |